These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31858867)

  • 1. Development and evaluation of paclitaxel nanoemulsion for cancer therapy.
    Shakhwar S; Darwish R; Kamal MM; Nazzal S; Pallerla S; Abu Fayyad A
    Pharm Dev Technol; 2020 Apr; 25(4):510-516. PubMed ID: 31858867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in-vitro characterization of nanoemulsions loaded with paclitaxel/γ-tocotrienol lipid conjugates.
    Abu-Fayyad A; Kamal MM; Carroll JL; Dragoi AM; Cody R; Cardelli J; Nazzal S
    Int J Pharm; 2018 Jan; 536(1):146-157. PubMed ID: 29195915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability.
    Abu-Fayyad A; Behery F; Sallam AA; Alqahtani S; Ebrahim H; El Sayed KA; Kaddoumi A; Sylvester PW; Carroll JL; Cardelli JA; Nazzal S
    Eur J Pharm Biopharm; 2015 Oct; 96():185-95. PubMed ID: 26235392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E.
    Abu-Fayyad A; Nazzal S
    Int J Pharm; 2017 Mar; 519(1-2):145-156. PubMed ID: 28093324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study.
    Liu H; Ma Y; Liu D; Fallon JK; Liu F
    J Biomed Nanotechnol; 2016 Jan; 12(1):147-53. PubMed ID: 27301180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of tocopherol-rich argan oil-based nanoemulsions as vehicles possessing anticancer activity.
    Jordan M; Nayel A; Brownlow B; Elbayoumi T
    J Biomed Nanotechnol; 2012 Dec; 8(6):944-56. PubMed ID: 23030003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection.
    Ledet GA; Biswas S; Kumar VP; Graves RA; Mitchner DM; Parker TM; Bostanian LA; Ghosh SP; Mandal TK
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol.
    Abu-Fayyad A; Nazzal S
    Int J Pharm; 2017 Aug; 529(1-2):75-86. PubMed ID: 28627454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
    Mu L; Feng SS
    J Control Release; 2002 Apr; 80(1-3):129-44. PubMed ID: 11943393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel.
    Sun Y; Yu B; Wang G; Wu Y; Zhang X; Chen Y; Tang S; Yuan Y; Lee RJ; Teng L; Xu S
    Colloids Surf B Biointerfaces; 2014 Nov; 123():716-23. PubMed ID: 25456995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
    Zhao L; Feng SS
    J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
    Win KY; Feng SS
    Biomaterials; 2006 Apr; 27(10):2285-91. PubMed ID: 16313953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response.
    Ye J; Dong W; Yang Y; Hao H; Liao H; Wang B; Han X; Jin Y; Xia X; Liu Y
    Pharm Res; 2017 Jun; 34(6):1244-1254. PubMed ID: 28326458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.